Day: November 3, 2022

CHICAGO, Nov. 3, 2022 /PRNewswire/ — Merck KGaA, Darmstadt, Germany, a leading science and technology company, and p-Chip Corporation, a company that is revolutionizing the tracking of physical products and materials with its breakthrough microtransponder technology, today announced the conclusion of a joint development agreement to develop and implement a new solution that offers never-before-seen levels of digital trust in machine-to-machine (M2M)-connected industrial value chains.

“The processes and technologies that power product development are evolving rapidly,” said Bill Eibon, CTO of p-Chip Corporation. “But methods for monitoring those processes need to keep up with production technology. This agreement will advance visibility, traceability and quality assurance to a level that is not only revolutionary, but also absolutely necessary for the machine-powered realities of our modern industrial value chains.”

The blockchain solution of Merck KGaA, Darmstadt, Germany is a patented technology that allows anchoring digital data with real-world objects by leveraging crypto anchors to create crypto objects and therefore creating digital twins. p-Chip microtransponder technology is used as a digital twin enabler for Merck KGaA, Darmstadt, Germany empowering Digital Twin features like digital traceability, human-machine collaboration, and complex processes automation through Smart Contracts.

The joint development agreement focuses on advancing M2M visibility and communication among thousands of companies and vendors.

Since 2017, p-Chip Corporation has revolutionized the tracking of physical products and materials with its breakthrough microtransponder technology. Highly durable and small as a grain of salt, its p-Chip crypto anchor functions like a digital twin for physical items, delivering breakthrough visibility and security at a scalable price point. From pharmaceuticals to electronics, automotive components to agricultural ingredients, companies worldwide rely on patented p-Chip microtransponders to unlock business intelligence, protect brand and product integrity, and enhance revenue. To learn more, visit www.p-chip.com.

Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across life science, healthcare and electronics. More than 60,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2021, Merck KGaA, Darmstadt, Germany, generated sales of € 19.7 billion in 66 countries.

The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany, operate as MilliporeSigma in life science, EMD Serono in healthcare and EMD Electronics in electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company.

libby cortez
libby.cortez@p-chip.com

Explore the potentials of Malaysia Healthcare at World Travel Market London 2022

LONDON, Nov. 3, 2022 /PRNewswire/ — Malaysia Healthcare is strengthening its global proposition for preventive healthcare via strategic partnerships at the World Travel Market 2022 (“WTM”) in London.

As a nation, Malaysia eagerly encourages global citizens to prioritise preventive care by taking charge of their health and well-being. Malaysia Healthcare is at the forefront of this phenomenon with a health system that has been evolving from curative care and treatments to preventive health and wellness. This has led to the debut of Malaysia Healthcare’s Premium Wellness Programme, an industry-wide collaborative effort with numerous top-tier private hospitals, hotels and travel companies in Malaysia which integrates comprehensive health screening with world-class hotel accommodation, leisure tour itinerary with options for healthcare travellers to add on dental aesthetics and cosmetic procedures as well as other treatments such as Hepatitis C, cancer, and heart screening.

“In line with the third Sustainable Development Goal (SDG) of the United Nations to ‘ensure healthy lives and promote wellbeing for all at all ages’, Malaysia is committed to consistently progressing our healthcare system to empower and encourage healthier lifestyles with enhanced health screening capabilities, for everyone,” said Mohd Daud Mohd Arif, Chief Executive Officer of the Malaysia Healthcare Travel Council (MHTC).

Malaysia is a top-of-mind destination for healthcare travellers from around the world and was awarded “Destination of the Year” by UK-based healthcare travel authority International Medical Travel Journal (IMTJ) in 2020.  Malaysia’s strong reputation as a destination for travel and healthcare attracted 1.06 million European tourists and 1.22 million healthcare travellers in 2019 alone, with the top 10 countries of arrivals to Malaysia for healthcare travel being Australia, Bangladesh, China, India, Indonesia, Japan, Singapore, Somalia, United Kingdom, and United States.

Malaysia’s niche treatment areas include cardiology, oncology, fertility, orthopaedics, neurology, and aesthetics such as bariatric treatments, as well as dental and other cosmetic services. In addition to its commitment to providing affordable, accessible, seamless, and end-to-end quality healthcare, it is also fortifying its healthcare offerings through strategic partnerships with travel agents and healthcare facilitators at regional and global levels.

Also present at WTM are the country’s tourism partners, including Tourism Malaysia and state tourism bodies from Sarawak, Sabah, Penang, Selangor, Johor, Perak and Melaka who work closely with Malaysia Healthcare, alongside leading private hospitals of Malaysia to provide a holistic and seamless healthcare experience through premium wellness packages. MHTC will also be signing a Memorandum of Understanding (MoU) with SHINON Healthcare, a leading medical assistance and healthcare consultant which assists patients to seek treatment outside of their country and act as their local guarding in the chosen destination. With healthcare travel being a key economic driver for Malaysia, WTM provides a synergistic platform for interested international parties to pursue business collaborations with Malaysia’s key stakeholders and realise opportunities for 2023 and beyond.

“We recognise how crucial it is to form strategic partnerships to catalyse industry recovery moving into 2023. It is key for Malaysia Healthcare to identify and join forces with other industry partners who share the same value system and commitment towards service excellence. We are at WTM London to reach out to travel agents and healthcare facilitators, whose markets have been historically coming to Malaysia for both healthcare and tourism opportunities, for collaborative opportunities and training programmes, such as the Health Facilitator Training Programme. Our intention is to ensure we engage the like-minded partners, such as SHINON Healthcare, in realising our ambition of offering the Best Healthcare Travel Experience,” continued Mohd Daud.

The Health Facilitator Training Programme is a capacity building effort aimed at equipping tour and travel agents with the necessary knowledge and skills to thereafter provide services to returning and potential healthcare travellers who recognise Malaysia as a preferred destination for healthcare.

“Malaysia is currently home to over 250 private healthcare facilities that are highly regulated by the Ministry of Health Malaysia (MOH) and recognised globally. The MOH oversees the ceiling rates for healthcare treatments in Malaysia, thus ensuring fair price structures for all healthcare travellers. As such, healthcare travellers are assured of accessible and affordable healthcare with little to no waiting time. We welcome all healthcare travellers to experience the best of healthcare travel with Malaysia Healthcare and take advantage of the seamless end-to-end services provided, from point of enquiry to post-treatment care,” said Mohd Daud.

Visit the Malaysia Healthcare booth at the Malaysia Pavilion this 7th to 9th November 2022 at World Travel Market at ExCel, London, for opportunities to network with representatives from Malaysia Healthcare and explore exclusive healthcare packages. For more information,  please visit https://www.malaysiahealthcare.org/, www.facebook.com/MHTCMalaysia or LinkedIn (Malaysia Healthcare Travel Council).

Photo – https://mma.prnewswire.com/media/1937265/MHlogoJul22_copy__1.jpg